A new opioid-related CME requirement by the federal government is now in effect.

Section 1263 of the Consolidated Appropriations Act of 2023, also known as the Medication Access and Training Expansion (MATE) Act, necessitates ALL DEA-registered practitioners who prescribe schedule II, III, IV or V drugs undergo a one-time, eight-hour training requirement incorporating education on the treatment and management of patients with opioid or other substance use disorders.

Prescribers must satisfy this new training requirement at the date of their next scheduled DEA registration submission – regardless of whether it is an initial or renewal registration. The law went into effect on June 27.

Haven’t met those requirements yet? ISMA has you covered.

More than 25 archived hours of qualifying opioid-related CME are already available on-demand FREE for members via the ISMA Online app, and we’ve created an FAQ to address common questions related to the act. In addition, multiple live, FREE opioid CME discussions are planned between now and Sept. 14.

Not a member? Join ISMA today to receive instant access to the entire CME archive and numerous other benefits. Nonmember physicians may subscribe to ISMA Online and all archived content through Dec. 31, 2023, for $400 – or join ISMA to receive this and other valuable membership benefits.